1.48
-0.07 (-4.52%)
| Previous Close | 1.55 |
| Open | 1.50 |
| Volume | 678,064 |
| Avg. Volume (3M) | 1,085,313 |
| Market Cap | 199,002,320 |
| Price / Earnings (Forward) | 142.86 |
| Price / Sales | 1.06 |
| Price / Book | 0.830 |
| 52 Weeks Range | |
| Earnings Date | 10 Feb 2026 |
| Profit Margin | 8.70% |
| Operating Margin (TTM) | -11.56% |
| Diluted EPS (TTM) | 0.130 |
| Quarterly Revenue Growth (YOY) | 74.30% |
| Total Debt/Equity (MRQ) | 2.24% |
| Current Ratio (MRQ) | 3.42 |
| Operating Cash Flow (TTM) | -15.60 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Organigram Global Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 0.83 |
|
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
| % Held by Insiders | 32.41% |
| % Held by Institutions | 5.59% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Baader Bank Aktiengesellschaft | 30 Sep 2025 | 263,915 |
| Formidable Asset Management, Llc | 31 Dec 2025 | 144,149 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 03 Feb 2026 | Announcement | Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 |
| 31 Dec 2025 | Announcement | Organigram Extends Innovation Investment with Phylos |
| 16 Dec 2025 | Announcement | Organigram Reports Record Fourth Quarter and Fiscal 2025 Results |
| 05 Dec 2025 | Announcement | Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 |
| 25 Nov 2025 | Announcement | Organigram Announces Appointment of Chief Executive Officer |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |